Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Dermatology and Dermatologic Surgery
mi
from
Danbury, CT
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Dermatology and Dermatologic Surgery
mi
from
Danbury, CT
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Park Avenue Dermatology
mi
from
Orange Park, FL
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Park Avenue Dermatology
mi
from
Orange Park, FL
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Research Institute of the Southeast
mi
from
West Palm Beach, FL
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Research Institute of the Southeast
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Visions Clincal Research
mi
from
West Palm Beach, FL
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Visions Clincal Research
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
MedaPhase, Inc.
mi
from
Newnan, GA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
MedaPhase, Inc.
mi
from
Newnan, GA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Gwinnett Clinical Research Center, Inc
mi
from
Snellville, GA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Gwinnett Clinical Research Center, Inc
mi
from
Snellville, GA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Laser & Skin Surgery Center of Indiana
mi
from
Carmel, IN
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Laser & Skin Surgery Center of Indiana
mi
from
Carmel, IN
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Research Institute of Deaconess Clinic
mi
from
Evansville, IN
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Research Institute of Deaconess Clinic
mi
from
Evansville, IN
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
DermAssociates, PC
mi
from
Rockville, MD
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
DermAssociates, PC
mi
from
Rockville, MD
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
ActivMed Practices & Research
mi
from
Methuen, MA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
ActivMed Practices & Research
mi
from
Methuen, MA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Clarkston Skin Research
mi
from
Clarkston, MI
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Clarkston Skin Research
mi
from
Clarkston, MI
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Clinical Studies Group, LLC
mi
from
Henderson, NV
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Clinical Studies Group, LLC
mi
from
Henderson, NV
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
The Dermatology Group, P.C.
mi
from
Verona, NJ
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
The Dermatology Group, P.C.
mi
from
Verona, NJ
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Skin Search of Rochester, Inc
mi
from
Rochester, NY
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Skin Search of Rochester, Inc
mi
from
Rochester, NY
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Suzanne Bruce and Associates The Center for Skin Research
mi
from
Katy, TX
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Suzanne Bruce and Associates The Center for Skin Research
mi
from
Katy, TX
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Austin Institute for Clinical Research, Inc.
mi
from
Pflugerville, TX
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Austin Institute for Clinical Research, Inc.
mi
from
Pflugerville, TX
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Premier Clinical Research
mi
from
Spokane, WA
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Surrey,
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Surrey,
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
The GW Medical Faculty Associates
mi
from
Washington,
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
The GW Medical Faculty Associates
mi
from
Washington,
Click here to add this to my saved trials
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Studies
mi
from
Houston, TX
A Trial to Compare the Incidence of SCC and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Incidence of Squamous Cell Carcinoma and Other Skin Neoplasia in Subjects With Actinic Keratosis Treated With Ingenol Disoxate Gel 0.018% or 0.037%, or Vehicle
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Studies
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
UNIVERSITY OF ALABAMA AT BIRMINGHAM (UAB), 1802 6th Ave S
mi
from
Birmingham, AL
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
UNIVERSITY OF ALABAMA AT BIRMINGHAM (UAB), 1802 6th Ave S
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
BURKE PHARMACEUTICAL RESEARCH LLC, 3633 Central Ave
mi
from
Hot Springs, AR
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
BURKE PHARMACEUTICAL RESEARCH LLC, 3633 Central Ave
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
NORTHWEST AR CLINICAL TRIALS CENTER, PLLC/HULL DERMATOLOGY, PA, 500 S 52nd Street
mi
from
Rogers, AR
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
NORTHWEST AR CLINICAL TRIALS CENTER, PLLC/HULL DERMATOLOGY, PA, 500 S 52nd Street
mi
from
Rogers, AR
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
THE VITILIGO & PIGMENTATION INSTITUE OF SOUTHERN CALIFORNIA, 5670 Wilshire Boulevard
mi
from
Los Angeles, CA
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
THE VITILIGO & PIGMENTATION INSTITUE OF SOUTHERN CALIFORNIA, 5670 Wilshire Boulevard
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
DERMATOLOGY RESEARCH ASSOCIATES- LOS ANGELES, 8930 S Sepulveda Blvd
mi
from
Los Angeles, CA
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
DERMATOLOGY RESEARCH ASSOCIATES- LOS ANGELES, 8930 S Sepulveda Blvd
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
CLINICAL RESEARCH CENTER OF CT, 27 Hospital Avenue
mi
from
Danbury, CT
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
CLINICAL RESEARCH CENTER OF CT, 27 Hospital Avenue
mi
from
Danbury, CT
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC/ AMERIDERM RESEARCH, 725 W Granada Blvd
mi
from
Ormond Beach, FL
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC/ AMERIDERM RESEARCH, 725 W Granada Blvd
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
EMORY UNIVERSITY, 1525 Clifton Road
mi
from
Atlanta, GA
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
EMORY UNIVERSITY, 1525 Clifton Road
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
NORTHWESTERN UNIVERSITY, 676 N Saint Clair
mi
from
Chicago, IL
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
NORTHWESTERN UNIVERSITY, 676 N Saint Clair
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center, 260 Tremont Street
mi
from
Boston, MA
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center, 260 Tremont Street
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
UNIVERSITY OF MASSACHUESETTS, 364 Plantation Street
mi
from
Worcester, MA
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
UNIVERSITY OF MASSACHUESETTS, 364 Plantation Street
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE DERMATOLOGY, 969 N. Mason Road
mi
from
Saint Louis, MO
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE DERMATOLOGY, 969 N. Mason Road
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
ACTIVMED PRACTICES AND RESEARCH, INC, 110 Corporate Drive
mi
from
Portsmouth, NH
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
ACTIVMED PRACTICES AND RESEARCH, INC, 110 Corporate Drive
mi
from
Portsmouth, NH
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI MEDICAL CENTER- DERMATOLOGY ASSOCIATES, 5 E 98th Street
mi
from
New York, NY
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI MEDICAL CENTER- DERMATOLOGY ASSOCIATES, 5 E 98th Street
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
WAKE FOREST UNIVERSITY HEALTH SCIENCES, Medical Center Boulevard
mi
from
Winston-Salem, NC
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
WAKE FOREST UNIVERSITY HEALTH SCIENCES, Medical Center Boulevard
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
CENTRAL SOONER RESEARCH, 900 N Porter Ave
mi
from
Norman, OK
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
CENTRAL SOONER RESEARCH, 900 N Porter Ave
mi
from
Norman, OK
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
RHODE ISLAND HOSPITAL, 593 Eddy Street
mi
from
Providence, RI
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
RHODE ISLAND HOSPITAL, 593 Eddy Street
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
ARLINGTON RESEARCH CENTER, INC., 711 East Lamar Boulevard
mi
from
Arlington, TX
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
ARLINGTON RESEARCH CENTER, INC., 711 East Lamar Boulevard
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
MENTER DERMATOLOGY RESEARCH INSTITUTE, 3900 Junius Street
mi
from
Dallas, TX
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
MENTER DERMATOLOGY RESEARCH INSTITUTE, 3900 Junius Street
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, DEPARTMENT OF DERMATOLOGY, 5323 Harry Hines Blvd
mi
from
Dallas, TX
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, DEPARTMENT OF DERMATOLOGY, 5323 Harry Hines Blvd
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
HAMZAVI DERMATOLOGY, 3031 W Grand Blvd
mi
from
Detroit, MI
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
HAMZAVI DERMATOLOGY, 3031 W Grand Blvd
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
DERMATOLOGY SPECIALISTS, INC, 3629 Vista Way
mi
from
Oceanside, CA
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
DERMATOLOGY SPECIALISTS, INC, 3629 Vista Way
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
DS RESEARCH, 2241 Green Valley Road
mi
from
New Albany, IN
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
DS RESEARCH, 2241 Green Valley Road
mi
from
New Albany, IN
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
THE DERMATOLOGY AND LASER CENTER OF SAN ANTONIO, 7810 Louis Pasteur
mi
from
San Antonio, TX
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
THE DERMATOLOGY AND LASER CENTER OF SAN ANTONIO, 7810 Louis Pasteur
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
DAWES FRETZIN CLINICAL RESEARCH GROUP, 8103 Clearvista Parkway
mi
from
Indianapolis, IN
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
DAWES FRETZIN CLINICAL RESEARCH GROUP, 8103 Clearvista Parkway
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated:  12/31/1969
TULANE UNIVERSITY, 1415 Tulane Avenue
mi
from
New Orleans, LA
A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
A Randomized, Double-Blind, Dose-Ranging Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
Status: Enrolling
Updated: 12/31/1969
TULANE UNIVERSITY, 1415 Tulane Avenue
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
DermResearch, Inc.
mi
from
Austin, TX
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Progressive Clinical Research
mi
from
San Antonio, TX
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Progressive Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials